- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01328743
Brief Alcohol Intervention for HIV-Infected Men Who Have Sex With Men (MSM) in a Primary Care Setting
August 1, 2019 updated by: Peter Monti, Brown University
This is a randomized clinical trial to examine the effects of a brief counseling intervention for heavy drinking HIV-infected men who have sex with men compared to HIV care as usual.
The study tests the hypothesis that brief counseling will lower drinking in these patients and that reductions in drinking will be associated with better HIV-related outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is a randomized clinical trial in which 224 heavy drinking men who have sex with men (MSM), who receive their HIV primary care at Fenway Health in Boston, are randomly assigned to treatment as usual (TAU) or TAU plus a brief intervention to reduce alcohol use (TAU-BI).
TAU-BI will be based in Motivational Interviewing and include personalized feedback tailored to an HIV-infected MSM population.
Follow-ups will occur at 3, 6, and 12 months.
The first primary aim of the study is to test the hypothesis that TAU-BI, compared to TAU, will result in reduced alcohol consumption over a 12-month follow-up period as indicated by: (1) a lower number of alcoholic drinks consumed per week; (2) a lower number of drinking days within each follow-up period; and (3) a lower number of heavy drinking days within each follow-up period.
The second primary aim is to test the hypothesis that greater reductions in alcohol use will be associated with (1) greater adherence to HIV medication regimens; (2) less engagement in high-risk sexual behavior that could result in HIV transmission; (3) lower plasma HIV RNA levels (viral load) (CD4 cell counts will be a secondary outcome in this sub-aim); (4) improved liver function tests; and (5) improved neurocognitive function.
Study Type
Interventional
Enrollment (Actual)
180
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Fenway Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- be at least 18 years of age
- drink heavily at least once per month on average (≥5 drinks) or drink more than 14 drinks per week
- have a confirmed diagnosis of HIV/AIDS
- be a male who has had sex (oral or anal) with a male partner in the past 3 months.
Exclusion Criteria:
- current intravenous drug use
- currently psychotic, suicidal, or manic
- are currently being treated or have been treated in the past 3 months for an HIV-related opportunistic infection
- currently receiving treatment for an alcohol or drug problem
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Treatment as usual
Treatment as usual in an HIV primary care setting.
Participants receive assessment of alcohol use but not counseling or advice regarding drinking.
|
|
Experimental: Brief Alcohol Intervention
Participants receive 3 face-to-face sessions of counseling on alcohol use and 2 follow-up phone calls
|
3 sessions of individual face-to-face counseling at baseline, 3 and 6 months.
Sessions are motivationally focused including discussion of pros and cons of drinking and feedback on health and its relation to heavy drinking
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Alcoholic Drinks Consumed
Time Frame: 12 months
|
Number of standard alcoholic drinks consumed per week in the past month
|
12 months
|
Number of Heavy Drinking Days
Time Frame: 12 months
|
Number of heavy drinking days (drinking 5 or more drinks in a day) in the past month
|
12 months
|
Number of Heavy Drinking Days
Time Frame: 6 months
|
Number of heavy drinking days (drinking 5 or more drinks in a day) in the past month
|
6 months
|
Number of Heavy Drinking Days
Time Frame: 3 months
|
Number of heavy drinking days (drinking 5 or more drinks in a day) in the past month
|
3 months
|
Number of Alcoholic Drinks Consumed
Time Frame: 3 months
|
Number of standard alcoholic drinks consumed per week in the past month
|
3 months
|
Number of Alcoholic Drinks Consumed
Time Frame: 6 months
|
Number of standard alcoholic drinks consumed per week in the past month
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Peter Monti, Ph.D., Brown University
- Study Director: Christopher Kahler, Ph.D., Brown University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (Actual)
July 1, 2016
Study Completion (Actual)
August 1, 2016
Study Registration Dates
First Submitted
March 31, 2011
First Submitted That Met QC Criteria
April 4, 2011
First Posted (Estimate)
April 5, 2011
Study Record Updates
Last Update Posted (Actual)
September 9, 2019
Last Update Submitted That Met QC Criteria
August 1, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- NIAAA-P01-AA019072-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
-
University of Maryland, BaltimoreWithdrawnHiv | Kidney Transplant | HIV Reservoir | CCR5United States
Clinical Trials on Brief alcohol intervention
-
University of Texas at AustinNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedDrinking Behavior | Injury RecidivismUnited States
-
University of VirginiaNational Cancer Institute (NCI); United States Air ForceCompleted
-
Syracuse UniversityCompleted
-
The University of Tennessee, KnoxvilleNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Butler HospitalUnknownAlcohol Use | Intimate Partner ViolenceUnited States
-
SangathCompletedHazardous DrinkingIndia
-
Centre for Addiction and Mental HealthCanadian Cancer Society (CCS)Completed
-
Peking UniversityActive, not recruitingAlcohol Use DisorderChina
-
Helse Stavanger HFOslo University Hospital; Sorlandet Hospital HF; Helse Nord-Trøndelag HF; Helse... and other collaboratorsRecruitingAlcohol Dependence | Alcohol; Harmful Use | Alcohol Consumption | Health Risk BehaviorsNorway
-
Centre for Addiction and Mental HealthUniversity Health Network, Toronto; Maple Leaf ResearchActive, not recruiting
-
University of California, Los AngelesNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedHeavy Drinking